Liang JD - Search Results

1

Safety and dose escalation of the targeted oncolytic adenovirus OBP-301 for refractory advanced liver cancer: Phase I clinical trial.

Heo J, Liang JD, Kim CW, Woo HY, Shih IL, Su TH, Lin ZZ, Yoo SY, Chang S, Urata Y, Chen PJ. Heo J, et al. Among authors: liang jd. Mol Ther. 2023 Jul 5;31(7):2077-2088. doi: 10.1016/j.ymthe.2023.04.006. Epub 2023 Apr 14. Mol Ther. 2023. PMID: 37060176 Clinical Trial.

2

In situ vaccination followed by intramuscular poly-ICLC injections for the treatment of hepatocellular carcinoma in mouse models.

Weng MT, Yang SF, Liu SY, Hsu YC, Wu MC, Chou HC, Chiou LL, Liang JD, Wang LF, Lee HS, Sheu JC. Weng MT, et al. Among authors: liang jd. Pharmacol Res. 2023 Feb;188:106646. doi: 10.1016/j.phrs.2023.106646. Epub 2023 Jan 5. Pharmacol Res. 2023. PMID: 36621619 Free article.

3

Current role of local ablative treatments for hepatocellular carcinoma.

Huang GT, Liang JD, Sheu JC. Huang GT, et al. Among authors: liang jd. J Formos Med Assoc. 2004 Jun;103(6):403-10. J Formos Med Assoc. 2004. PMID: 15278182 Review.

4

Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma.

Ou DL, Shen YC, Liang JD, Liou JY, Yu SL, Fan HH, Wang DS, Lu YS, Hsu C, Cheng AL. Ou DL, et al. Among authors: liang jd. Clin Cancer Res. 2009 Sep 15;15(18):5820-8. doi: 10.1158/1078-0432.CCR-08-3294. Epub 2009 Sep 8. Clin Cancer Res. 2009. PMID: 19737956

5

Safety of Perfluorobutane (Sonazoid) in Characterizing Focal Liver Lesions.

Chou YH, Liang JD, Wang SY, Hsu SJ, Hu JT, Yang SS, Wang HK, Lee TY, Tiu CM. Chou YH, et al. Among authors: liang jd. J Med Ultrasound. 2019 Apr-Jun;27(2):81-85. doi: 10.4103/JMU.JMU_44_19. Epub 2019 Jun 24. J Med Ultrasound. 2019. PMID: 31316217 Free PMC article.

6

Quality of life and its associated factors in patients with hepatocellular carcinoma receiving one course of transarterial chemoembolization treatment: a longitudinal study.

Shun SC, Chen CH, Sheu JC, Liang JD, Yang JC, Lai YH. Shun SC, et al. Among authors: liang jd. Oncologist. 2012;17(5):732-9. doi: 10.1634/theoncologist.2011-0368. Epub 2012 Apr 17. Oncologist. 2012. PMID: 22511265 Free PMC article.

7

Three-dimensional power Doppler ultrasonography for demonstrating associated arteries of hepatocellular carcinoma.

Liang JD, Yang PM, Liang PC, Huang GT, Sheu JC, Chen DS. Liang JD, et al. Among authors: liang pc. J Formos Med Assoc. 2003 Jun;102(6):367-74. J Formos Med Assoc. 2003. PMID: 12923588

8

Percutaneous microwave coagulation therapy under ultrasound guidance for small hepatocellular carcinoma.

Liang JD, Yang PM, Huang GT, Lee HS, Chen CH, Liang PC, Sheu JC, Chen DS. Liang JD, et al. Among authors: liang pc. J Formos Med Assoc. 2004 Dec;103(12):908-13. J Formos Med Assoc. 2004. PMID: 15624039

9

Hepatocellular carcinoma with duodenal invasion and metastasis.

Liang JD, Chen CH, Hsu SJ, Sheu JC, Yang PM, Lee HS, Lee CZ, Huang GT. Liang JD, et al. J Gastroenterol Hepatol. 2012 Apr;27(4):677-83. doi: 10.1111/j.1440-1746.2011.06869.x. J Gastroenterol Hepatol. 2012. PMID: 21793909

10

Neoantigen vaccination augments antitumor effects of anti-PD-1 on mouse hepatocellular carcinoma.

Yang SF, Weng MT, Liang JD, Chiou LL, Hsu YC, Lee YT, Liu SY, Wu MC, Chou HC, Wang LF, Yu SH, Lee HS, Sheu JC. Yang SF, et al. Among authors: liang jd. Cancer Lett. 2023 Jun 1;563:216192. doi: 10.1016/j.canlet.2023.216192. Epub 2023 Apr 22. Cancer Lett. 2023. PMID: 37088327 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63 results

Search Page